Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,411,033
-
Total 13F shares
-
56,687,549
-
Share change
-
+2,310,606
-
Total reported value
-
$187,637,541
-
Put/Call ratio
-
443%
-
Price per share
-
$3.31
-
Number of holders
-
101
-
Value change
-
+$7,269,182
-
Number of buys
-
45
-
Number of sells
-
56
Institutional Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q2 2024
As of 30 Jun 2024,
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,687,549 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, BML Capital Management, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and Almitas Capital LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.